$497 Million is the total value of BROADWOOD CAPITAL INC's 7 reported holdings in Q4 2013. The portfolio turnover from Q3 2013 to Q4 2013 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| QCOR | Sell | QUESTCOR PHARMACEUTICALS INC | $152,278,000 | -20.4% | 2,796,660 | -15.2% | 30.62% | -25.0% |
| STAA | Buy | STAAR SURGICAL CO | $111,502,000 | +28.6% | 6,887,095 | +7.6% | 22.42% | +21.2% |
| MNST | Sell | MONSTER BEVERAGE CORP | $108,373,000 | +28.9% | 1,599,136 | -0.6% | 21.79% | +21.5% |
| MNST | MONSTER BEVERAGE CORPput | $67,770,000 | +29.7% | 1,000,000 | 0.0% | 13.63% | +22.2% | |
| BTX | Buy | BIOTIME INC | $33,560,000 | -2.1% | 9,322,262 | +3.3% | 6.75% | -7.8% |
| CYNO | CYNOSURE INCcl a | $21,766,000 | +16.8% | 817,029 | 0.0% | 4.38% | +10.1% | |
| SLTM | SOLTA MED INC | $2,008,000 | +42.5% | 680,723 | 0.0% | 0.40% | +34.2% |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2014-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| STAAR SURGICAL CO | 42 | Q3 2023 | 59.1% |
| MONSTER BEVERAGE CORP NEW | 34 | Q3 2023 | 49.7% |
| ISHARES TR | 33 | Q3 2023 | 14.8% |
| ONCOCYTE CORPORATION | 31 | Q2 2023 | 4.6% |
| BIOTIME INC | 25 | Q2 2019 | 17.8% |
| AXON ENTERPRISE INC | 24 | Q3 2023 | 13.4% |
| AGEX THERAPEUTICS INC | 20 | Q3 2023 | 1.5% |
| LINEAGE CELL THERAPEUTICS INC | 17 | Q3 2023 | 5.1% |
| ASTERIAS BIOTHERAPEUTICS INC | 16 | Q4 2018 | 2.9% |
| CYNOSURE INC | 15 | Q4 2016 | 10.4% |
View BROADWOOD CAPITAL INC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2024-04-15 |
| 13F-HR | 2024-02-14 |
| 4 | 2024-02-08 |
| 4 | 2024-01-10 |
| 4 | 2024-01-05 |
| 4 | 2023-11-30 |
| 13F-HR | 2023-11-14 |
| 4 | 2023-11-14 |
| 4 | 2023-11-09 |
| 4 | 2023-11-06 |
View BROADWOOD CAPITAL INC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.